Info Obat dan Regulator Obat Dunia

F
Frequently Asked Questions about Labeling for Prescription Medicines
Replies
0
Views
236
FDA
F
F
Prescription Drug Labeling Contact Information
Replies
0
Views
335
FDA
F
F
Guidance, Compliance, & Regulatory Information
Replies
0
Views
279
FDA
F
F
Peripheral and Central Nervous System Drugs Advisory Committee Charter
Replies
0
Views
338
FDA
F
F
Nonprescription Drugs Advisory Committee Roster
Replies
0
Views
305
FDA
F
F
Office of Study Integrity and Surveillance (OSIS) Workshop 2022: CDER Inspections of Good Laboratory Practice, Animal Rule, and Bioavailability/Bioequ
Replies
0
Views
313
FDA
F
F
GSK Consumer Healthcare Issues Voluntary Nationwide Recall of Children's Robitussin® Honey Cough and Chest Congestion DM and Children's Dimetapp® Cold
Replies
0
Views
428
FDA
F
F
Real Clean Distribuciones SA de CV Issues Voluntary Nationwide Recall of Four Hand Sanitizer Due to Potential Presence of Undeclared Methanol (Wood Al
Replies
0
Views
312
FDA
F
F
Anidulafungin Injection
Replies
0
Views
213
FDA
F
F
Mixing Medications and Dietary Supplements Can Endanger Your Health
Replies
0
Views
321
FDA
F
F
Rationale for FDA’s Position on Oxacillin Breakpoints for Staphylococcus
Replies
0
Views
431
FDA
F
F
FDA-Recognized Antimicrobial Susceptibility Test Interpretive Criteria
Replies
0
Views
256
FDA
F
F
Search for Regulatory References | Drugs
Replies
0
Views
236
FDA
F
F
Office of Generic Drugs | Offices and Divisions
Replies
0
Views
273
FDA
F
F
Ukoniq (umbralisib): Drug Safety Communication - FDA Approval of Lymphoma Medicine is Withdrawn Due to Safety Concerns
Replies
0
Views
328
FDA
F
F
Walmart Inc. Issues Voluntary Nationwide Recall of Various Artri Ajo King Joint Supplements Due to Potential Hidden Drug Ingredients
Replies
0
Views
347
FDA
F
E
EMA appoints Chief Medical Officer , , 01/06/2022
Replies
0
Views
273
EMA
E
F
FDA approves Opdivo in combination with chemotherapy and Opdivo in combination with Yervoy for first-line esophageal squamous cell carcinoma indicatio
Replies
0
Views
261
FDA
F
F
FDA approves tisagenlecleucel for relapsed or refractory follicular lymphoma
Replies
0
Views
261
FDA
F
F
Quality Management Maturity Workshop - 05/24/2022
Replies
0
Views
274
FDA
F
You must log in or register to post here.
Top